April 18, 2014

Study: Higher Cholesterol Levels Associated with Longer Life – Statin Drugs Useless

Cholesterol chemical structure Study: Higher Cholesterol Levels Associated with Longer Life   Statin Drugs Useless


by Dr. Brownstein

If you have high cholesterol levels you should take a statin right? That is the mantra promoted by conventional medicine. In fact, statins have become the most profitable class of medications sold by The Big Pharma Cartel.

I have seen countless patients who have been told by their doctor that if they don’t take a statin drug they are putting themselves in line for heart attack.

However, that is not what the research has found. Did you know that:

1. There is no indication for taking a statin drug if you have not had a cardiac event.
2. If you are a man and have had a cardiac event, the best the statins drugs can promise you is approximately a 1-5% reduction in preventing a non-fatal heart attack.
3. Even though they have been around for over 15 years, statin drugs have never been shown to prolong lives.
4. In women there are no solid studies that demonstrate that it is beneficial to take a statin drug for any purpose.

The Cochrane Collaboration, an independent group that is not associated with Big Pharma money stated, “Statins do not have a proven net health benefit in primary prevention populations and thus when used in that setting do not represent good use of scarce health care resources.” (1)

A recent (2013) study found that high cholesterol and LDL-cholesterol levels in subjects over 50 years was associated with lowered all-cause mortality. (2) Compared to those with cholesterol <190mg/dL, those aged 60-70 years with a cholesterol level from 190-230mg/dL had a 32% lowered mortality rate. Those with a cholesterol level from 230-308mg/dL had a 33% reduced mortality rate. For male subjects with a cholesterol over 308mg/dL, there was an insignificant 2% increase risk for all-cause mortality. Women fared better. Compared to those with a cholesterol of less than 190mg/dL, women with cholesterol levels from 190-308mg/dL had a 41-43% reduction in all-cause mortality. Similarly to men, cholesterol levels over 308mg/dL had an insignificant (2%) rise in all-cause mortality.

Folks, this study is nothing new. Low cholesterol levels are associated with an increased risk of cancer, neurological disorders and muscle disorders. There are many studies showing increased longevity in older people (over 59 years old) who have higher cholesterol levels. Keep in mind that cholesterol is needed by every cell in the body to optimally function.

I stated in my book, Drugs that Don’t Work and Natural Therapies That Do, “You can’t poison a crucial enzyme and expect a good long-term result.” Statins poison a crucial enzyme in the body—HMG CoA Reductase. The result of poisoning this enzyme is disastrous—the chemical lowering of cholesterol is associated with disorders of the neurological and muscular systems.

The promotion of statins defies logic. The widespread use of this class of medications doesn’t make either biochemical or common sense. Mark my words; In the future, the widespread use of statins will be shown to be a drastic mistake in medicine.

(1) Therapeutics Letter 77/ March-April 2010
(2) Scandinavian J. of Primary Health Care. 2013;31:172-80

Read the Full Article Here: http://blog.drbrownstein.com/another-nail-in-the-statin-coffin/

Fat and Cholesterol are Good for You!
What REALLY Causes Heart Disease
by Uffe Ravnskov, MD, PhD

fat and cholesterol are good for you Study: Higher Cholesterol Levels Associated with Longer Life   Statin Drugs Useless

Free Shipping Available!

0 commentsback to post

Other articlesgo to homepage

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

U.S Congressman: CDC Can’t be Trusted Regarding Vaccine Safety

Congressman Bill Posey’s strong resolve and demands for transparency were evident as he discussed the Center for Disease Control (CDC)’s handling of vaccine safety studies which affect “our most precious resource in our nation – our children.” The 30-minute interview, conducted by vaccine industry watchdog, PhD biochemist Brian Hooker, delves into what Posey called “the incestuous relationship between the public health community and the vaccine makers and public officials.”

The Florida legislator, known as “Mr. Accountabililty,” did not mince words when criticizing current and past CDC officials including indicted fraudster Dr. Poul Thorsen; CDC director turned Merck Vaccine President Dr. Julie Gerberding; and the agency’s current spokesperson regarding autism and vaccines, Dr. Coleen Boyle.

Congressman Posey said, “The CDC can’t be trusted regarding investigating vaccine safety. Huge conflict of interest. I think the CDC should be investigated.”

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

Merck’s Former Doctor Predicts that Gardasil will Become the Greatest Medical Scandal of All Time

In an interview with Dr. Bernard Dalbergue, a former pharmaceutical industry physician with Gardasil manufacturer Merck, he predicts that Gardasil will become the greatest medical scandal of all time. Dr. Dalbergue believes that at some point in time, the evidence will add up to prove that this vaccine, technical and scientific feat that it may be, has absolutely no effect on cervical cancer and that all the very many adverse effects which destroy lives and even kill young girls, serves no other purpose than to generate profit for the manufacturers.

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

Deadly Medicines and Organized Crime: How big pharma has corrupted healthcare

An important new book by a recognized medical research expert describes Big Pharma as akin to the Mafia. In an interview conducted by our colleagues at ANH-Europe, Dr. Peter C. Gøtzsche exposes the flaws of the drug approval system, our reliance on dangerous drugs, and the deadly co-dependence between regulators and industry. Dr. Gøtzsche is co-founder of the highly respected Cochrane Collaboration and Cochrane Reviews, a leading journal of evidence-based medicine. The interview is particularly timely now that the FDA has decided to remove restrictions on the dangerous drug Avandia.

Dr. Gøtzsche’s new book, Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare, points out that the pharmaceutical industry is allowed to test their own drugs, and thus effectively be their own judge. He calls this a threat to safe medicine and asks for open access to all research data, including raw data, because otherwise, data can be easily suppressed and conclusions manipulated by industry.

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical Cannabis is a Threat to the Pharmaceutical Industry

Medical marijuana, or cannabis, is legal in 20 US states, where it is used for a variety of medical conditions such as mood disorders, pain disorders, multiple sclerosis, and even cancer. Parents of children with epilepsy met at a news conference to share their dismay that Governor Mark Dayton refuses to legalize medical marijuana. About 85 percent to 95 percent of Americans are in favor of medical cannabis, and nearly 60 percent are in favor of legalizing marijuana. Cannabis shows outstanding promise as a medicinal plant, largely due to its cannabidiol (CBD) content. Cannabinoids interact with your body by way of naturally occurring cannabinoid receptors embedded in cell membranes throughout your body.

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Pharmaceutical company payments to doctors extend far beyond rank-and-file clinicians — and deep into the leadership of America’s teaching hospitals, according to a study published recently in the Journal of the American Medical Association.

A team of researchers at the University of Pittsburgh Medical Center examined the boards of the 50 largest drug companies by global sales (excluding three companies that were not publicly traded). The researchers found that 40 percent — 19 companies — had at least one board member who also held a leadership role at an academic medical center. Sixteen of the 17 companies based in the United States had at least one. Several had more than one. All told, the research team found that 41 of the companies’ 2012 board members held leadership positions at academic medical centers. Six of the 41 were pharmaceutical company executives who served on hospital boards of directors or held other leadership posts.

The authors wrote that when academic medical leaders serve on pharmaceutical company boards, it can lead to conflicts not only for individuals, but for the critically important health care institutions they guide.

read more


Get the news right in your inbox!